The acquisition was completed on a cash-free, debt-free basis, with an upfront consideration of ₹400 crore and a potential additional payout of up to ₹72.5…

NTPC to raise ₹4,000 crore through non-convertible debentures (NCDs) on June 17, 2025, to fund capital expenditure, loan refinancing, and other corporate needs. Meanwhile, the…

Rekha Jhunjhunwala has brought her stake in Nazara Technologies down to zero, selling shares worth ₹334 crore on June 13 as the gaming stock surged…

The financial results will be formally presented to the board on July 23 for final approval. Shares of Infosys Ltd ended at ₹1601.55, down by…

The facility can continue selling approved drugs and will also receive approvals for new filings. Shares of Syngene International Ltd ended at ₹652.45, down by…

Within Indian equities, small-cap stocks outperformed across all timeframes, delivering 21% returns over the past three months, 39% from the market bottom in March 2020,…

Zydus and Lupin launched the generic version of Myrbetriq at risk in April 2025.

In the week ended June 13, the FIIs offloaded ₹1,246 crore amount of equities, while domestic institutional investors (DIIs) continued their buying streak with net…

Ganorkar has been heading the India business of Sun Pharma since 2019 and will take over as MD effective September 1, 2025. Shares of Sun…

Birla Corporation, as the highest bidder, has agreed to pay 20.60% of the value of the limestone it extracts from the block to the Rajasthan…